Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection.

Rivino L, Kumaran EA, Jovanovic V, Nadua K, Teo EW, Pang SW, Teo GH, Gan VC, Lye DC, Leo YS, Hanson BJ, Smith KG, Bertoletti A, Kemeny DM, MacAry PA.

J Virol. 2013 Mar;87(5):2693-706. doi: 10.1128/JVI.02675-12. Epub 2012 Dec 19.

2.

Dengue virus-specific CD4+ and CD8+ T lymphocytes target NS1, NS3 and NS5 in infected Indian rhesus macaques.

Mladinich KM, Piaskowski SM, Rudersdorf R, Eernisse CM, Weisgrau KL, Martins MA, Furlott JR, Partidos CD, Brewoo JN, Osorio JE, Wilson NA, Rakasz EG, Watkins DI.

Immunogenetics. 2012 Feb;64(2):111-21. doi: 10.1007/s00251-011-0566-0. Epub 2011 Sep 1. Erratum in: Immunogenetics. 2012 Mar;64(3):259-60.

PMID:
21881953
3.

CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination.

Yauch LE, Prestwood TR, May MM, Morar MM, Zellweger RM, Peters B, Sette A, Shresta S.

J Immunol. 2010 Nov 1;185(9):5405-16. doi: 10.4049/jimmunol.1001709. Epub 2010 Sep 24.

4.

Dengue virus-infected human dendritic cells reveal hierarchies of naturally expressed novel NS3 CD8 T cell epitopes.

Piazza P, Campbell D, Marques E, Hildebrand WH, Buchli R, Mailliard R, Rinaldo CR.

Clin Exp Immunol. 2014 Sep;177(3):696-702. doi: 10.1111/cei.12373.

5.

Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection.

Mathew A, Kurane I, Green S, Stephens HA, Vaughn DW, Kalayanarooj S, Suntayakorn S, Chandanayingyong D, Ennis FA, Rothman AL.

J Virol. 1998 May;72(5):3999-4004.

6.

Differential in vivo clearance and response to secondary heterologous infections by H2(b)-restricted dengue virus-specific CD8+ T cells.

Beaumier CM, Jaiswal S, West KY, Friberg H, Mathew A, Rothman AL.

Viral Immunol. 2010 Oct;23(5):477-85. doi: 10.1089/vim.2010.0034.

7.

Distinct activation phenotype of a highly conserved novel HLA-B57-restricted epitope during dengue virus infection.

Townsley E, Woda M, Thomas SJ, Kalayanarooj S, Gibbons RV, Nisalak A, Srikiatkhachorn A, Green S, Stephens HA, Rothman AL, Mathew A.

Immunology. 2014 Jan;141(1):27-38. doi: 10.1111/imm.12161.

8.

The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes.

Weiskopf D, Angelo MA, Bangs DJ, Sidney J, Paul S, Peters B, de Silva AD, Lindow JC, Diehl SA, Whitehead S, Durbin A, Kirkpatrick B, Sette A.

J Virol. 2015 Jan;89(1):120-8. doi: 10.1128/JVI.02129-14. Epub 2014 Oct 15.

9.

Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1.

Duan Z, Guo J, Huang X, Liu H, Chen X, Jiang M, Wen J.

J Med Virol. 2015 Jul;87(7):1077-89. doi: 10.1002/jmv.24167. Epub 2015 Mar 16.

PMID:
25777343
10.

Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a.

Mathew A, Kurane I, Rothman AL, Zeng LL, Brinton MA, Ennis FA.

J Clin Invest. 1996 Oct 1;98(7):1684-91.

11.

Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection.

Weiskopf D, Angelo MA, Sidney J, Peters B, Shresta S, Sette A.

J Virol. 2014 Oct;88(19):11383-94. doi: 10.1128/JVI.01108-14. Epub 2014 Jul 23.

12.

Identification and immunogenicity of two new HLA-A*0201-restricted CD8+ T-cell epitopes on dengue NS1 protein.

Tian J, Zeng G, Pang X, Liang M, Zhou J, Fang D, Liu Y, Li D, Jiang L.

Int Immunol. 2012 Apr;24(4):207-18. doi: 10.1093/intimm/dxr115. Epub 2012 Jan 31.

PMID:
22298881
13.

Functionality of dengue virus specific memory T cell responses in individuals who were hospitalized or who had mild or subclinical dengue infection.

Jeewandara C, Adikari TN, Gomes L, Fernando S, Fernando RH, Perera MK, Ariyaratne D, Kamaladasa A, Salimi M, Prathapan S, Ogg GS, Malavige GN.

PLoS Negl Trop Dis. 2015 Apr 13;9(4):e0003673. doi: 10.1371/journal.pntd.0003673. eCollection 2015 Apr.

14.
15.

Recombinant Dengue 2 Virus NS3 Helicase Protein Enhances Antibody and T-Cell Response of Purified Inactivated Vaccine.

Simmons M, Sun P, Putnak R.

PLoS One. 2016 Apr 1;11(4):e0152811. doi: 10.1371/journal.pone.0152811. eCollection 2016.

16.
18.

Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes.

Gao G, Wang Q, Dai Z, Calcedo R, Sun X, Li G, Wilson JM.

Hum Gene Ther. 2008 Sep;19(9):927-36. doi: 10.1089/hum.2008.011.

PMID:
18788905
19.

Immunodominant Dengue Virus-Specific CD8+ T Cell Responses Are Associated with a Memory PD-1+ Phenotype.

de Alwis R, Bangs DJ, Angelo MA, Cerpas C, Fernando A, Sidney J, Peters B, Gresh L, Balmaseda A, de Silva AD, Harris E, Sette A, Weiskopf D.

J Virol. 2016 Apr 14;90(9):4771-9. doi: 10.1128/JVI.02892-15. Print 2016 May.

20.

Human CD8+ T-Cell Responses Against the 4 Dengue Virus Serotypes Are Associated With Distinct Patterns of Protein Targets.

Weiskopf D, Cerpas C, Angelo MA, Bangs DJ, Sidney J, Paul S, Peters B, Sanches FP, Silvera CG, Costa PR, Kallas EG, Gresh L, de Silva AD, Balmaseda A, Harris E, Sette A.

J Infect Dis. 2015 Dec 1;212(11):1743-51. doi: 10.1093/infdis/jiv289. Epub 2015 May 15.

Supplemental Content

Support Center